CIK: 0001637359
Total reported value
$163.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | REPL | Replimune Group INC | Stock-Other | 36.13% | +0.33% | +0.40% | |
| 2 | MORFUSD | Morphic Holding INC | Stock-Other | 22.01% | — | +0.20% | |
| 3 | GOSS | Gossamer Bio INC | Stock-Other | 11.80% | — | -22.34% | |
| 4 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 6.98% | — | — | |
| 5 | VTLUSD | Immunic INC | Stock-Other | 4.54% | — | — | |
| 6 | PRTKEUR | Paratek Pharmaceuticals INC | Stock-Other | 3.71% | — | +0.09% | |
| 7 | EPIEUR | Essa Pharma INC | Stock-Other | 2.54% | — | -11.39% | |
| 8 | TRVI | Trevi Therapeutics INC | Stock-Other | 2.48% | — | +8.90% | |
| 9 | BEAM | Beam Therapeutics INC | Stock-Other | 2.32% | — | — | |
| 10 | ✓ | Cidara Therapeutics INC Com New | Stock-Other | 2.02% | — | -0.14% | |
| 11 | ✓ | Obseva SA | Stock-Other | 1.61% | — | — | |
| 12 | FGENEUR | Fibrogen INC | Stock-Other | 1.45% | — | — | |
| 13 | JNCEEUR | Jounce Therapeutics INC | Stock-Other | 1.00% | — | — | |
| 14 | ✓ | Prevail Therapeutics INC | Stock-Other | 0.76% | — | -31.26% | |
| 15 | PIRSEUR | Pieris Pharmaceuticals INC | Stock-Other | 0.64% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | REPL | Replimune Group INC | +14.3% | +0.40% | Add |
| 2 | MORFUSD | Morphic Holding INC | +4% | +0.20% | Add |
| 3 | VTLUSD | Immunic INC | +1.1% | — | Unchanged |
| 4 | TRVI | Trevi Therapeutics INC | +0.8% | +8.90% | Add |
| 5 | ✓ | Obseva SA | +0.6% | — | Unchanged |
| 6 | PRTKEUR | Paratek Pharmaceuticals INC | +0.3% | +0.09% | Add |
| 7 | BEAM | Beam Therapeutics INC | +0.1% | — | Unchanged |
| 8 | ✓ | Cidara Therapeutics INC Com New | 0% | -0.14% | Trim |
| 9 | JNCEEUR | Jounce Therapeutics INC | 0% | — | Unchanged |
| 10 | PIRSEUR | Pieris Pharmaceuticals INC | -0.1% | — | Unchanged |
| 11 | EPIEUR | Essa Pharma INC | -0.3% | -11.39% | Trim |
| 12 | FGENEUR | Fibrogen INC | -0.4% | — | Unchanged |
| 13 | ✓ | Prevail Therapeutics INC | -0.6% | -31.26% | Trim |
| 14 | ARQT | Arcutis Biotherapeutics INC | -3.4% | — | Unchanged |
| 15 | GOSS | Gossamer Bio INC | -6.2% | -22.34% | Trim |
| 16 | ✓ | Translate Bio INC | — | EXIT | Sold out |